Eddeland A, Ohlsson K
Scand J Clin Lab Invest. 1978 Oct;38(6):507-15. doi: 10.1080/00365517809108812.
Complexes between human or canine trypsin and the pancreatic secretory trypsin inhibitor (PSTI) from the same species were studied in vitro and in vivo. The following results were obtained. (1) Human or dog PSTI-trypsin complex without serum did not show any signs of dissociation after 3 h incubation at room temperature. (2) Immediate separation of reaction mixtures of human or canine serum and the corresponding PSTI-trypsin complexes by gel filtration showed that 60--70% of the trypsin was found in complex with alpha2-macroglobulin and the remainder in equal amounts in complex with alpha1-antitrypsin and PSTI, respectively. (3) The results of in vivo studies in dog indicated a similar rapid dissociation of the complexes in the circulation. (4) The elimination for intravenously administered 125I-labelled PSTI was rapid to about 20% of the initial value with a half-life of about 8 min for the initial part of the curve. No organ accumulation of the labelled inhibitor was found. (5) Most of the radioactivity injected was recovered in the urine bound to degradation products but part of it was bound to biologically active inhibitor.
对人或犬类胰蛋白酶与来自同一物种的胰腺分泌性胰蛋白酶抑制剂(PSTI)之间的复合物进行了体外和体内研究。得到了以下结果。(1)不含血清的人或犬PSTI - 胰蛋白酶复合物在室温下孵育3小时后未显示出任何解离迹象。(2)通过凝胶过滤立即分离人或犬血清与相应的PSTI - 胰蛋白酶复合物的反应混合物,结果显示60 - 70%的胰蛋白酶与α2 - 巨球蛋白形成复合物,其余部分分别与α1 - 抗胰蛋白酶和PSTI等量形成复合物。(3)犬体内研究结果表明循环中的复合物也有类似的快速解离。(4)静脉注射125I标记的PSTI的消除速度很快,在曲线初始部分半衰期约为8分钟,约20%达到初始值。未发现标记抑制剂在器官中蓄积。(5)注射的大部分放射性在尿液中与降解产物结合而被回收,但部分与生物活性抑制剂结合。